Loiasis

11 registered clinical trials studyying Loiasis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	21-day Double-blind Trial of Albendazole in Adults With Loa Loa Microfilaremia NCT06613997	Programme National de Lutte contre l'Onchocercose, Republic of the Congo	Phase 3
Recruiting	A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects NCT06252961	Programme National de Lutte contre l'Onchocercose, Republic of the Congo	Phase 2 / Phase 3
Recruiting	Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination NCT06350851	Bioaster	N/A
Withdrawn	Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa NCT04035174	Center for Research on Filariasis and Other Tropical Diseases, Cameroon	N/A
Completed	Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfil NCT04049851	Center for Research on Filariasis and Other Tropical Diseases, Cameroon	Phase 2
Completed	Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events NCT05085665	Washington University School of Medicine	Phase 4
Completed	Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients NCT04049630	Programme National de Lutte contre l'Onchocercose, Republic of the Congo	Phase 2
Unknown	Spontaneous Antigenemia in Loiasis NCT04258670	Washington University School of Medicine	—
Terminated	Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa NCT02644525	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis NCT01593722	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 4
Completed	Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis NCT01111305	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2